SGLT-2 inhibitors may cut dementia risk in patients with diabetes
By
Haymarket Media
Sep 03, 2024
The findings show a greater effect with longer treatment, compared with dipeptidyl peptidase-4 inhibitors.
COVID-19 continues to affect leading causes of death in US: CDC
By
Kimberly Bonvissuto
Aug 12, 2024
The COVID-19 pandemic radically altered the rankings of the leading causes of death in the United States in 2020, and although COVID ranks lower on the list of causes in 2023, its effects continue to be...
HbA1c stability tied to lower risk for Alzheimer disease and related dementias
Aug 08, 2024
The findings were seen in a large study of older veterans with diabetes.
Metformin displayed a lowest risk for dementia across diverse antidiabetics, while α-glucosidase inhibitors had the highest risk.
Your favorite columns of 2023
Dec 20, 2023
Assisted living regulation, government relations, ageism and pop culture, solutions for the middle market, and chronic disease and resident care were some of the column topics that especially grabbed the...
Life expectancy decreasing, CDC says
By
Lois A. Bowers
Aug 15, 2018
Life expectancy in the United States decreased in both 2015 and 2016, marking the only decreases in the past 20 years and the first consecutive two-year decline since 1964, according to a new report from...
Medicare Diabetes Prevention telehealth program expected to continue through 2023
By
John Roszkowski
May 02, 2023
The Medicare Diabetes Prevention Program’s telehealth capabilities will not cease when the public health emergency is allowed to sunset in nine days, allowing program providers more time to resume in-person...
Where dementia is most prevalent
By
Lois A. Bowers
Feb 03, 2016
A new tool from the federal government provides county- and state-level prevalence data for Alzheimer’s/dementia and 15 other chronic conditions.
Biden pledges to lower prescription drug prices for Americans
Dec 07, 2021
But the biggest policy change — letting Medicare negotiate prices for prescription drugs — will not start to lower costs until 2025.
Thiazolidinedione monotherapy for T2DM tied to lower dementia risk
Oct 12, 2022
Sulfonylurea monotherapy was linked to increased risk for all-cause dementia compared with metformin monotherapy.